These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36827097)

  • 1. A Survey of Didemnin Depsipeptide Production in
    Stankey RJ; Johnson D; Duggan BM; Mead DA; La Clair JJ
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial biosynthesis and maturation of the didemnin anti-cancer agents.
    Xu Y; Kersten RD; Nam SJ; Lu L; Al-Suwailem AM; Zheng H; Fenical W; Dorrestein PC; Moore BS; Qian PY
    J Am Chem Soc; 2012 May; 134(20):8625-32. PubMed ID: 22458477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Semisynthesis Platform for the Efficient Production and Exploration of Didemnin-Based Drugs.
    Zhang H; Li X; Hui Z; Huang S; Cai M; Shi W; Lin Y; Shen J; Sui M; Lai Q; Shao Z; Dou J; Luo X; Ge Y; Tang X
    Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202318784. PubMed ID: 38291557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B.
    Tsukimoto M; Nagaoka M; Shishido Y; Fujimoto J; Nishisaka F; Matsumoto S; Harunari E; Imada C; Matsuzaki T
    J Nat Prod; 2011 Nov; 74(11):2329-31. PubMed ID: 22035372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products as probes of cell biology: 20 years of didemnin research.
    Vera MD; Joullié MM
    Med Res Rev; 2002 Mar; 22(2):102-45. PubMed ID: 11857636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal and molecular structure of didemnin A, an antiviral depsipeptide.
    Hossain MB; Van Der Helm D; Antel J; Sheldrick GM; Weinheimer AJ; Sanduja SK
    Int J Pept Protein Res; 1996; 47(1-2):20-7. PubMed ID: 8907495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abi Family Protein, DidK, Is Involved in the Maturation of Anticancer Depsipeptide, Didemnin B.
    Jia K; Wang J; Zhai R; Du Y; Kira J; Wu C; Qian PY; Zhang W
    ACS Chem Biol; 2023 Oct; 18(10):2300-2308. PubMed ID: 37773034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry.
    Celli N; Gallardo AM; Rossi C; Zucchetti M; D'Incalci M; Rotilio D
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):335-43. PubMed ID: 10510788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications.
    Lee Y; Phat C; Hong SC
    Peptides; 2017 Sep; 95():94-105. PubMed ID: 28610952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiwavelength videomicrofluorometric study of cytotoxic effects of a marine peptide, didemnin B, on normal and MDR resistant CCRF-CEM cell lines.
    Rocchi E; Vigo J; Viallet P; Bonnard I; Salmon JM
    Anticancer Res; 2000; 20(2A):987-96. PubMed ID: 10810386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.
    Geldof AA; Mastbergen SC; Henrar RE; Faircloth GT
    Cancer Chemother Pharmacol; 1999; 44(4):312-8. PubMed ID: 10447579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison.
    Le Tourneau C; Raymond E; Faivre S
    Curr Pharm Des; 2007; 13(33):3427-39. PubMed ID: 18045196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor compounds from tunicates.
    Rinehart KL
    Med Res Rev; 2000 Jan; 20(1):1-27. PubMed ID: 10608919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamandarins A and B: new cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae.
    Vervoort H; Fenical W; Epifanio RA
    J Org Chem; 2000 Feb; 65(3):782-92. PubMed ID: 10814011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure--activity relationships of the didemnins.
    Sakai R; Rinehart KL; Kishore V; Kundu B; Faircloth G; Gloer JB; Carney JR; Namikoshi M; Sun F; Hughes RG; García Grávalos D; de Quesada TG; Wilson GR; Heid RM
    J Med Chem; 1996 Jul; 39(14):2819-34. PubMed ID: 8709112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of didemnin B, a depsipeptide from the sea.
    Li LH; Timmins LG; Wallace TL; Krueger WC; Prairie MD; Im WB
    Cancer Lett; 1984 Jul; 23(3):279-88. PubMed ID: 6744252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
    Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
    Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha.
    Crews CM; Collins JL; Lane WS; Snapper ML; Schreiber SL
    J Biol Chem; 1994 Jun; 269(22):15411-4. PubMed ID: 8195179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates.
    Urdiales JL; Morata P; Núñez De Castro I; Sánchez-Jiménez F
    Cancer Lett; 1996 Apr; 102(1-2):31-7. PubMed ID: 8603376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.